41233-93-6

Usage

InChI:InChI=1/C5H11O.K/c1-4-5(2,3)6;/h4H2,1-3H3;/q-1;+1

Upstream product

• 75-85-4 tert-Amyl alcohol 
• 78-79-5 isoprene 

Downstream Products

• 188818-06-6 N-benzyl-2-methylene-aziridine 
• 216754-32-4 3-[2-(2-fluorophenyl)-1-oxoethyl]-4-(R)-phenyl-2-oxazolidinone 
• 83511-12-0 acetic p-anisic anhydride 
• 791-28-6 Triphenylphosphine oxide 
• 179948-13-1 2-tert-butyl-6-(3-tert-butyl-2-hydroxy-5-methylphenylmethyl)-4-methylphenyl 3-(octylthio)propanoate 
• 2881-83-6 ethyl 4-methoxybenzoylacetate 
• 589-81-1 3-methylheptane 
• 2785-29-7 benzyl potassium 
• 1372814-60-2 N,N’-bis(2,6-diisopropylphenyl)imidazol-2-ylidene gold(I) hydroxide 

Relevant academic research and scientific papers

6-Oxoestradiols from estradiols: Exploiting site selective metalation of aralkyl systems with superbases

3-O-Protected estradiol derivatives undergo metalation at C-6 when exposed to a fourfold excess of the reagent consisting of an equimolar mixture of lithium diisopropylamide and potassium 1,1-dimethylpropoxide (3 h, THF, -78°C). The metalated intermediates can be oxidized by quenching with trimethyl borate followed by treatment with hydrogen peroxide, thus allowing the introduction of a 6-hydroxy group into the estradiol framework. Further oxidation of the 6-hydroxy group gives O-protected 6-oxoestradiols.

The hetero-cubane structures of the heavy alkali metal: Tert -amyloxides [MOCMe2Et]4 (M = K, Rb, Cs)

A series of alkali metal (Li-Cs) alkoxides of tert-pentanol (1,1-dimethylpropan-1-ol) have been prepared by reaction of the corresponding metal with the alcohol in n-hexane or n-heptane. The compounds were purified by vacuum sublimation and crystallised in n-hexane to produce crystals suitable for single-crystal X-ray diffraction studies. The structures of the potassium, rubidium, and caesium compounds revealed tetrameric units with additional intra- and intermolecular interactions between the metal atom and alkoxide methyl groups, increasing with the size of the metal involved.

Antiangiogenic agents

Compositions and methods for treating mammalian diseases or conditions characterized by undesirable angiogenesis by administering an effective amount of a compound of the formulae: wherein Ra is selected from —OCH3, —OCH2CH3 or —CCCH3; and Z is selected from >C(H)—OH, >C(H)—O-alkyl, >C(H)—O-sulfamate, where alkyl is a linear, branched and/or cyclic hydrocarbon chain comprising 1 to 10 carbons.

Method for producing alkali metal alcoholates

The invention relates to a method for producing alkali metal alcoholates by reacting alcohol with alkali metal in an aprotic, organic solvent in the presence of an H acceptor such as e.g. isoprene, butadiene, styrene or methyl styrene.